Skip to main content
. 2017 Mar 8;9(4):482–497. doi: 10.15252/emmm.201606975

Table 3.

Clinicopathological parameters from the validation cohort of patients

Patient distribution (validation cohort)
All (%) Resectable Unresectable
n 16 7 9
Sex
Male 10 (62.5) 3 7
Female 6 (37.5) 4 2
Age
Mean 69 67 70
Min–Max 53–83 58–71 53–83
Other cancers
No 11 (68.75) 4 7
Yes 5 (31.25) 3 2
Tumor location
Head 5 (31.25) 3 2
Undefined 2 (12.5) 0 2
Body 2 (12.5) 1 1
Tail 7 (43.75) 3 4
Specimen type
Primary tumor 13 (81.25) 7 6
Hepatic metastasis 2 (12.5) 0 2
Carcinomatosis 1 (6.25) 0 1
Tumor status at diagnosis
Localized 7 (43.75) 7 0
Locally advanced 1 (6.25) 0 1
Metastasis 6 (37.5) 0 6
Carcinomatosis 2 (12.5) 0 2